University Hospitals Urology Institute | Strategic Alliance Partners

“About 25% of men didn't even want to know that they had cancer,” says Daniel E. Spratt, MD.

“Patients just need to be educated that you don't have to live this way,” says J. Welles Henderson, MD, FACOG.

Patients classified as high-risk by the genomic classifier who underwent radical prostatectomy had a 3-fold higher risk of harboring adverse pathology at the time of surgery compared with those with low-risk.

Anna L. Myers, APRN-CNP, WHNP-BC, FNP-BC, IF, and Jean Marino, ARPN-CNP, NCMP, IF, preview an upcoming University Hospitals-led symposium titled, “What’s your pelvic floor plan? 2nd Annual Female Sexual Health Symposium.”

University Hospitals Urology Institute is excited to announce that this coming fall, the department is hosting 2 educational courses in cutting-edge urologic specialties: female sexual health and gender care.

“The real immediate use case is that this biomarker can be an adjunct, or it can be something to assist in making the shared decision making with patients [with prostate cancer],” says Daniel E. Spratt, MD.

"The thing that's unique about this course, in my opinion, is that we are combining the vaginoplasty and phalloplasty discussions," says Kirtishri Mishra, MD.

"It could identify about 2/3 of men that normally we'd be recommending hormone therapy would appear to have no benefit from hormone therapy," says Daniel E. Spratt, MD.

Dr. Vince has an interest in disparities in urologic care, specifically among patients with prostate cancer.

"I tried to highlight how race has been used in medical research, specifically analyzing how this may [be] used toward Black people as a way to uphold systems of oppression," says Randy Vince, Jr., MD, MS.

“Combined MRI-targeted and systematic biopsies were nearly twice as likely to result in downgraded pathology at prostatectomy compared [with] systematic biopsies," says Ilon C. Weinstein.

"What we found was a very different frequency of alterations in important genes," says Camilo Arenas-Gallo, MD.

"Something that we did find that was more promising was that regardless of whether a patient did or did not have a mental health disorder diagnosis, that did not affect their rate of receiving gender-affirming medical therapy," says Helen Sun, MD.

"I think there's going to be a rapid adoption of artificial intelligence platforms in our field," says David Sheyn, MD.

"UH is working on starting clinics throughout rural Northeast Ohio, and we're meeting to develop a FPMRS program, both virtual and in-person, so patients can have access to this point of care," says David Sheyn, MD.

“I am interested in looking at postpartum issues for sexual function,” says Rachel Pope, MD, MPH.

"UH is working on starting clinics throughout rural Northeast Ohio, and we're meeting to develop a FPMRS program, both virtual and in-person, so patients can have access to this point of care," says David Sheyn, MD.

"The overarching goal is to both increase the identification of patients with urinary incontinence as well as shorten the time between diagnosis and appropriate treatment," says David Sheyn, MD.

“For a lot of women with lichen sclerosis, they actually go for years without being diagnosed,” says Rachel Pope, MD, MPH.

“I would have to say the most exciting part of the whole conference was how many medical students and trainees were there,” says Rachel Pope, MD, MPH.

"The MMAI model had significantly improved accuracy and prognostication to discriminate which patients would develop distant metastasis or die from prostate cancer," says Daniel E. Spratt, MD.

“I would just burn it into everyone's brain that pain with intercourse is also going to be associated with genitourinary syndrome of menopause,” says Rachel Pope, MD, MPH.

“There's a huge potential role for urologists out there for female sexual health,” says Rachel Pope, MD, MPH.

“There are just a lot of barriers, unfortunately, to speaking freely about women's sexual health,” says Rachel Pope, MD, MPH.

“It didn't happen overnight. The way we built the program was an iterative process,” says Shubham Gupta, MD.

“The short-term goals are really community building [and] relationship building,” says Randy Vince Jr, MD.

“Coordination between urology and radiation oncology, if urology is placing the device, is really critical,” says Jonathan E. Shoag, MD.

“Each patient is different, and some patients are more challenging than others in terms of placement,” says Jonathan E. Shoag, MD.

“It's really the overall excellence of a multidisciplinary program focused on improving patient outcomes,” says Daniel E. Spratt, MD.

The device helps reduce unintentional side effects of prostate cancer therapy.